Chair 

Dr Julia Dixon-Douglas
Medical Oncologist
Peter MacCallum Cancer Centre

A recipient of the Breast Cancer Trials International Fellowship grant in 2023, Dr Julia Dixon-Douglas recently returned from Institut Gustave Roussy in Paris, France, where she spent two and a half years working in translational research as part of her PhD, as well as working with the multidisciplinary breast service at Gustave Roussy and contributing to their liquid biopsy precision medicine program.

Speaker

Dr Alison Schram MD
Associate Attending Physician Section Head, Oral Therapeutics Early Drug Development and Gynecologic Medical Oncology Services, Memorial Sloan Kettering Cancer Center

Dr Schram is a medical oncologist and clinical investigator at the Memorial Sloan Kettering Cancer Center in New York, USA. Her work focuses on early-phase clinical trials and the development of new, targeted cancer therapies.

Dr Schram’s research aims to identify and target the molecular changes that drive tumours, helping to tailor treatments to individual patients through precision oncology approaches. She leads and contributes to early drug development studies designed to bring promising therapies from the laboratory into clinical trials for patients with advanced cancers.

She earned her MD from the University of Pennsylvania School of Medicine and completed her internal medicine residency at Brigham and Women’s Hospital, followed by a fellowship in medical oncology at Memorial Sloan Kettering. In addition to her clinical and research roles, Dr Schram has received recognition for her contributions to clinical research, including awards supporting innovative cancer investigation and leadership in clinical trials.